BioSpace News Archive

Modalis Therapeutics Corporation, a leading company developing innovative products for the treatment of rare genetic diseases utilizing its proprietary CRISPR-GNDM epigenetic gene modulation technology, reported financial results for the third quarter ended September 30, 2020, as well as recent operational highlights.

Blood group typing is a process of identifying type of blood that a person has. The process depends on the level of antigens on Red Blood Cells present.

Over the past decade, neurointerventional techniques have gained increased significance in the management of acute ischemic strokes.

Significant reduction of synovitis (joint lining inflammation) was demonstrated with Cosentyx® at Week 12 vs. placebo, with improvements as early as Week 11

Commercial Manufacturing Base Settled in Suzhou BioBAY for the Development of Pharmaceutical Industry

Hutchison China MediTech Limited announces that initial analysis of the first in human HMPL-689 Phase I dose escalation study will be presented as a poster at the upcoming 62nd American Society of Hematology Annual Meeting and Exposition, taking place on December 5-8, 2020 virtually.

Encision Inc., a medical device company owning patented Active Electrode Monitoring Technology that prevents dangerous stray electrosurgical burns in minimally invasive surgery, announced financial results for its fiscal 2021 second quarter that ended September 30, 2020.

RadNet, Inc. announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will be presenting at the Jefferies Virtual London Healthcare Conference on Thursday, November 19, 2020 at 10:10 a.m. Pacific Time.

BD, a leading global medical technology company, reported quarterly revenues of $4.784 billion for the fourth fiscal quarter ended September 30, 2020.

DENTSPLY SIRONA Inc., The Dental Solutions Company, announced its financial results for the three months ended September 30, 2020.